Primary Image

Generic Background Image

Clinical Trial

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits after mTBI plus PTSD

IRB Protocol Number STU00203773

Contact

Katie Kestner ckestner@sralab.org

Objective

The purpose of this study is to alleviate persisting attention deficits related to mild TBI and PTSD by treating the neurocognitive system of attention.

Who Can Participate

  • Mild TBI/concussive event 3 months to 10 years ago
  • Have co-occuring mild TBI and PTSD

Compensation

Provided

Age Range

18-80

Apply for this Trial

Your information will not be published.

All fields are required.

Featured Quote

More Studies Like This

Intensive Attention Training To Treat Brain Fog In Individuals With Long-COVID

The goal of this study is to test the feasibility and effectiveness of an attention training intervention as a potential treatment for brain fog symptoms (forgetfulness, confusion, or lack of focus) experienced by people with Long-Covid.

read more
view all

Latest Updates

view all